The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has five committees: three for Product Development Awards (committee A, committee B and committee C), one for Challenge Awards, and one for Connect.
Committee members - Product Development Awards Selection Committee C
Name | Position | Organisation | Expertise |
---|---|---|---|
Ms Joanna Smart (Chair) |
Investor Director |
BGF |
Ms Smart has been active in the life sciences sector for over 20 years, as a CEO, non-executive chair and board director with experience in operating roles in SMEs, startups, global biotech, and investment banking. |
Dr Matthew Reeves (Deputy Chair) |
Associate Professor/Reader in Molecular Virology |
University College London |
Dr Reeves has a specialty in infectious diseases focusing primarily on human cytomegalovirus latency and reactivation, and viral pathogenesis in human transplantation. |
Professor Philip Breedon |
Professor of Smart Technologies |
Nottingham Trent University |
Professor Breedon is a medical design engineer with interests in wearable and rehabilitation technologies, Extended Reality, AI, surgical and mobile robotics and the surgical pathway. |
Mr Mark Campbell |
Independent healthtech consultant |
Self-employed |
Mr Campbell advises companies, life science organisations and public sector agencies on value proposition development, evidence generation and health technology assessment for devices, diagnostics and digital health technologies. |
Mr Ravi Chana |
Head of Business Development |
Roche Diagnostics UK Limited |
Mr Chana has a broad range of expertise in business development, market access, health economics, medtech commercialisation and value based healthcare.
|
Professor Liam Grover |
Professor of Biomaterials Science and Director of the Healthcare Technologies Institute |
University of Birmingham |
Professor Grover is a biomaterials scientist whose research focuses on designing materials that enhance the tissue regeneration process. |
Professor Gail Hayward |
Associate Professor |
University of Oxford |
Professor Hayward is a practising GP and experienced in diagnostics and infectious diseases research in primary care. |
Mr Derek Jerome |
Public Committee Member |
PPI Representative |
PPI Representative |
Professor Paul Leeson |
Professor of Cardiovascular Medicine, University of Oxford |
University of Oxford |
Professor Leeson is a consultant cardiologist with expertise in using AI and imaging to develop novel approaches to cardiovascular disease management. |
Professor Luca Marciani |
Professor of Gastrointestinal Imaging |
University of Nottingham |
Professor Marciani is a physicist with expertise in biomedical and translational imaging research and particular interests in magnetic resonance imaging and medical devices. |
Professor James Moore |
The Bagrit and Royal Academy of Engineering Chair in Medical Device Design |
Imperial College London |
Professor Moore has experience of research commercialisation and his interests include cardiovascular biomechanics, implantable devices, and the lymphatic system. |
Dr Nick de Pennington |
CEO
|
Ufonia Limited |
Dr de Pennington is a former neurosurgeon with experience in digital innovation, health AI and clinical entrepreneurship. |
Dr Andrew Sims |
Head of Department, Northern Medical Physics and Clinical Engineering |
The Newcastle upon Tyne Hospitals NHS Foundation Trust; Freeman Hospital, Newcastle upon Tyne
|
Dr Sims is a medical physicist specialising in technology assessment of medical devices and diagnostics. He has expertise in medical image analysis and research commercialisation. |
Ms Alexina Weekes |
Public Committee Member |
PPI Representative |
PPI Representative |
Dr Neville Young |
Director of Enterprise & Innovation |
Health Innovation Yorkshire and Humber |
Dr Young has experience with innovative surgical tools, intraoperative imaging systems, novel biosensing diagnostics, nanotechnology and remote monitoring.
|